Erwin Friedrich Wagner | Academic Influence

Erwin Friedrich Wagner's AcademicInfluence.com Rankings

Erwin Friedrich Wagner

Biology

#1359

World Rank

#2293

Historical Rank

Molecular Biology

#201

World Rank

#205

Historical Rank

Biochemistry

#451

World Rank

#532

Historical Rank

biology Degrees

Download Badge

Biology

Erwin Friedrich Wagner's Degrees

PhD Biochemistry University of Vienna

Why Is Erwin Friedrich Wagner Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Erwin Friedrich Wagner is an Austrian biochemist known for his research on the molecular basis of cancer and associated conditions such as inflammation and cachexia. He was deputy director of the Spanish National Cancer Research Center in Madrid, Spain, until 2019. Since 2019, Wagner is a group leader affiliated with the Medical University of Vienna.

(See a Problem?)

Erwin Friedrich Wagner's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 (2018) (3106)
Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. (2002) (2255)
Signal integration by JNK and p38 MAPK pathways in cancer development (2009) (2216)
Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells (1988) (2070)
AP-1: a double-edged sword in tumorigenesis (2003) (1980)
Evidence for osteocyte regulation of bone homeostasis through RANKL expression (2011) (1476)
Reaching a genetic and molecular understanding of skeletal development. (2002) (1372)
Defective Lipolysis and Altered Energy Metabolism in Mice Lacking Adipose Triglyceride Lipase (2006) (1227)
Strain-dependent epithelial defects in mice lacking the EGF receptor. (1995) (1045)
A Validated Regulatory Network for Th17 Cell Specification (2012) (991)
Bone and haematopoietic defects in mice lacking c-fos (1992) (935)
Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5 BSAP (1994) (873)
Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon. (1999) (839)
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015 (2014) (799)
Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. (1995) (786)
Autoamplification of NFATc1 expression determines its essential role in bone homeostasis (2005) (771)
AP-1 in mouse development and tumorigenesis (2001) (735)
RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β (2002) (712)
Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation (1999) (687)
Imprinted expression of the Igf2r gene depends on an intronic CpG island (1997) (600)
PARP is important for genomic stability but dispensable in apoptosis. (1997) (592)
Hormone-sensitive Lipase Deficiency in Mice Causes Diglyceride Accumulation in Adipose Tissue, Muscle, and Testis* (2002) (583)
Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins (2005) (580)
Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors (1985) (552)
c-Jun is essential for normal mouse development and hepatogenesis (1993) (548)
Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. (1986) (535)
The Molecular Clock Mediates Leptin-Regulated Bone Formation (2005) (532)
Nuclear Factor of Activated T-cells (NFAT) Rescues Osteoclastogenesis in Precursors Lacking c-Fos* (2004) (524)
A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. (2014) (507)
Regulation of embryonic growth and lysosomal targeting by the imprintedIgf2/Mpr gene (1994) (501)
Fos/AP‐1 proteins in bone and the immune system (2005) (490)
The AP-1 Transcription Factor c-Jun Is Required for Efficient Axonal Regeneration (2004) (472)
Liver Tumor Development c-Jun Antagonizes the Proapoptotic Activity of p53 (2003) (467)
A Probabilistic Functional Network of Yeast Genes (2004) (451)
JunB Deficiency Leads to a Myeloproliferative Disorder Arising from Hematopoietic Stem Cells (2004) (400)
Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. (2004) (393)
Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2 (1999) (382)
Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin (1999) (373)
p38α suppresses normal and cancer cell proliferation by antagonizing the JNK–c-Jun pathway (2007) (365)
NF-κB p50 and p52 Regulate Receptor Activator of NF-κB Ligand (RANKL) and Tumor Necrosis Factor-induced Osteoclast Precursor Differentiation by Activating c-Fos and NFATc1* (2007) (358)
Osteoblasts are target cells for transformation in c-fos transgenic mice (1993) (355)
Impaired Long-Term Memory and NR2A-Type NMDA Receptor-Dependent Synaptic Plasticity in Mice Lacking c-Fos in the CNS (2003) (352)
The absence of c-fos prevents light-induced apoptotic cell death of photoreceptors in retinal degeneration in vivo (1997) (345)
A strain‐independent postnatal neurodegeneration in mice lacking the EGF receptor (1998) (340)
JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development (1999) (326)
JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms (2002) (323)
Embryonic lethality and fetal liver apoptosis in mice lacking the c‐raf‐1 gene (2001) (323)
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 (2018) (323)
Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1 (2000) (322)
JunB suppresses cell proliferation by transcriptional activation of p16INK4a expression (2000) (321)
Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation (2000) (316)
Deregulated c-fos expression interferes with normal bone development in transgenic mice (1987) (314)
Lesion-induced increase in nerve growth factor mRNA is mediated by c-fos. (1990) (314)
Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation. (2008) (313)
The EGF Receptor Provides an Essential Survival Signal for SOS-Dependent Skin Tumor Development (2000) (308)
The Mammalian UV Response c-Jun Induction Is Required for Exit from p53-Imposed Growth Arrest (2000) (306)
Osteoclasts are essential for TNF-alpha-mediated joint destruction. (2002) (300)
Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease (2008) (289)
Requirement of JNK2 for Scavenger Receptor A-Mediated Foam Cell Formation in Atherogenesis (2004) (281)
c-Jun regulates eyelid closure and skin tumor development through EGFR signaling. (2003) (275)
The human beta-globin gene and a functional viral thymidine kinase gene in developing mice. (1981) (267)
Functions of c-Jun in Liver and Heart Development (1999) (267)
Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling. (2003) (265)
Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c‐jun in the liver (2002) (264)
Differentiation of F9 teratocarcinoma stem cells after transfer of c-fos proto-oncogenes (1984) (261)
Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment (1989) (258)
JunB is essential for mammalian placentation (1999) (253)
Functions of AP1 (Fos/Jun) in bone development (2002) (253)
Fra-1 replaces c-Fos-dependent functions in mice. (2000) (250)
Chronic Myeloid Leukemia with Increased Granulocyte Progenitors in Mice Lacking JunB Expression in the Myeloid Lineage (2001) (247)
Stat5 tetramer formation is associated with leukemogenesis. (2005) (245)
C-Jun Nh2-Terminal Kinase (Jnk)1 and Jnk2 Have Similar and Stage-Dependent Roles in Regulating T Cell Apoptosis and Proliferation (2001) (244)
Genetic control of skeletal development. (2001) (243)
Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene (1988) (242)
Genetic analysis of p38 MAP kinases in myogenesis: fundamental role of p38α in abrogating myoblast proliferation (2007) (239)
IκB kinase (IKK)β, but not IKKα, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss (2005) (235)
Targeting inflammation by modulating the Jun/AP-1 pathway (2011) (232)
Specific pathophysiological functions of JNK isoforms in the brain (2005) (228)
Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin (2012) (224)
c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity. (2006) (219)
Mechanisms of metabolic dysfunction in cancer-associated cachexia (2016) (216)
Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation (2000) (214)
The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice. (1996) (212)
Psoriasis: what we have learned from mouse models (2010) (202)
Conditional inactivation of VEGF-A in areas of collagen2a1 expression results in embryonic lethality in the heterozygous state. (2000) (200)
Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects (2004) (196)
Activation of ERK1/2 by ΔRaf-1 : ER* represses Bim expression independently of the JNK or PI3K pathways (2003) (193)
The Fos‐related antigen Fra‐1 is an activator of bone matrix formation (2004) (192)
Promoter Specificity and Biological Activity of Tethered AP-1 Dimers (2002) (186)
Down‐regulation of wild‐type p53 activity interferes with apoptosis of IL‐3‐dependent hematopoietic cells following IL‐3 withdrawal. (1994) (185)
Genetic interaction between PARP and DNA-PK in V(D)J recombination and tumorigenesis (1997) (185)
S100A8-S100A9 protein complex mediates psoriasis by regulating the expression of complement factor C3. (2013) (182)
c-fos expression induces bone tumors in transgenic mice. (1989) (180)
Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia (2008) (177)
Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1 (2008) (173)
Regulation of ES cell differentiation by functional and conformational modulation of p53 (1997) (170)
The origins of oncomice: a history of the first transgenic mice genetically engineered to develop cancer. (2007) (164)
c-Jun-Dependent CD95-L Expression Is a Rate-Limiting Step in the Induction of Apoptosis by Alkylating Agents (2000) (164)
Mouse models for liver cancer (2013) (161)
MKK7 couples stress signalling to G2/M cell-cycle progression and cellular senescence (2004) (158)
EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer (2008) (156)
Prenatal lethalities in mice homozygous for human growth hormone gene sequences integrated in the germ line (1983) (153)
Placental vascularisation requires the AP-1 component fra1. (2000) (153)
JunB can substitute for Jun in mouse development and cell proliferation (2002) (151)
Expression of interstitial collagenase during skeletal development of the mouse is restricted to osteoblast-like cells and hypertrophic chondrocytes. (1995) (151)
Jun signalling in the epidermis: From developmental defects to psoriasis and skin tumors. (2006) (150)
JNK phosphorylation relieves HDAC3‐dependent suppression of the transcriptional activity of c‐Jun (2003) (149)
c-fos-induced osteosarcoma formation in transgenic mice: cooperativity with c-jun and the role of endogenous c-fos. (1995) (149)
Phosphate‐Dependent Regulation of MGP in Osteoblasts: Role of ERK1/2 and Fra‐1 (2009) (148)
Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells. (2010) (145)
Inhibition of de novo NAD(+) synthesis by oncogenic URI causes liver tumorigenesis through DNA damage. (2014) (143)
Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis (2009) (141)
Analysis of the differentiation‐promoting potential of inducible c‐fos genes introduced into embryonal carcinoma cells. (1985) (139)
Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heart (2003) (138)
Clustered homeo boxes are differentially expressed during murine development (1985) (138)
Anti-oncogenic activity of signalling-defective epidermal growth factor receptor mutants (1992) (137)
Transgenic Activation of Ras in Neurons Promotes Hypertrophy and Protects from Lesion-Induced Degeneration (2000) (137)
Non-imprinted Igf2r expression decreases growth and rescues the Tme mutation in mice. (2001) (137)
AP-1 – Introductory remarks (2001) (132)
A miR‐34a‐SIRT6 axis in the squamous cell differentiation network (2013) (129)
Generation of completely embryonic stem cell-derived mutant mice using tetraploid blastocyst injection (1997) (128)
Expression of retroviral vectors in transgenic mice obtained by embryo infection. (1987) (126)
Targeting miR-21 to Treat Psoriasis (2014) (125)
Chronic skin inflammation leads to bone loss by IL-17–mediated inhibition of Wnt signaling in osteoblasts (2016) (123)
Loss of Vascular Endothelial Growth Factor A Activity in Murine Epidermal Keratinocytes Delays Wound Healing and Inhibits Tumor Formation (2004) (121)
Fos and bone cell development: lessons from a nuclear oncogene. (1995) (119)
Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun) (2009) (119)
p38alpha: a suppressor of cell proliferation and tumorigenesis. (2007) (117)
Neuronal survival depends on EGFR signaling in cortical but not midbrain astrocytes (2006) (117)
p38α: A Suppressor of Cell Proliferation and Tumorigenesis (2007) (117)
Chronic inflammation imposes aberrant cell fate in regenerating epithelia through mechanotransduction (2015) (116)
Fos and jun proteins are specifically expressed during differentiation of human keratinocytes. (2005) (116)
Differential effects of JNK1 and JNK2 on signal specific induction of apoptosis (2002) (113)
Fra-2/AP-1 controls bone formation by regulating osteoblast differentiation and collagen production (2010) (109)
Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression (2014) (107)
Degeneration of neural cells in the central nervous system of mice deficient in the gene for the adhesion molecule on Glia, the beta 2 subunit of murine Na,K-ATPase (1994) (105)
A Central Role for the JNK Pathway in Mediating the Antagonistic Activity of Pro-inflammatory Cytokines against Transforming Growth Factor-β-driven SMAD3/4-specific Gene Expression* (2003) (103)
Early fetal hematopoietic development from in vitro differentiated embryonic stem cells. (1991) (100)
Defective induction but normal activation and function of p53 in mouse cells lacking poly-ADP-ribose polymerase (1997) (99)
Jun N-terminal kinase 2 modulates thymocyte apoptosis and T cell activation through c-Jun and nuclear factor of activated T cell (NF-AT). (2001) (97)
Erratum: Corrigendum: The European dimension for the mouse genome mutagenesis program (2004) (95)
Essential role of RSK2 in c-Fos-dependent osteosarcoma development. (2005) (95)
Specific roles for dendritic cell subsets during initiation and progression of psoriasis (2014) (94)
JunD regulates lymphocyte proliferation and T helper cell cytokine expression (2004) (94)
Regulation of steatohepatitis and PPARγ signaling by distinct AP-1 dimers. (2014) (92)
Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade. (2003) (91)
Defective Angiogenesis Delays Thrombus Resolution: A Potential Pathogenetic Mechanism Underlying Chronic Thromboembolic Pulmonary Hypertension (2014) (90)
The AP1 transcription factor Fra2 is required for efficient cartilage development (2004) (88)
JNK2: A Negative Regulator of Cellular Proliferation (2004) (86)
Transcriptional Regulation of EGR-1 by the Interleukin-1-JNK-MKK7-c-Jun Pathway* (2008) (85)
c-Jun Controls Histone Modifications, NF-κB Recruitment, and RNA Polymerase II Function To Activate the ccl2 Gene (2008) (85)
Transcriptional regulation by NR5A2 links differentiation and inflammation in the pancreas (2018) (84)
Human beta-globin gene sequences injected into mouse eggs, retained in adults, and transmitted to progeny. (1982) (84)
Polyoma Middle T-induced Vascular Tumor Formation: The Role of the Plasminogen Activator/Plasmin System (1997) (84)
IL-4 Confers NK Stimulatory Capacity to Murine Dendritic Cells: A Signaling Pathway Involving KARAP/DAP12-Triggering Receptor Expressed on Myeloid Cell 2 Molecules1 (2004) (82)
JunB inhibits proliferation and transformation in B-lymphoid cells. (2003) (82)
Embryonic stem (ES) cells lacking functional c-jun: consequences for growth and differentiation, AP-1 activity and tumorigenicity. (1992) (81)
Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes. (2001) (80)
c-fos expression interferes with thymus development in transgenic mice (1988) (79)
Expression of human alpha 1-acid glycoprotein genes in cultured cells and in transgenic mice. (1988) (78)
Antagonistic control of cell fates by JNK and p38-MAPK signaling (2008) (75)
Impaired intervertebral disc formation in the absence of Jun (2003) (75)
Liver carcinogenesis by FOS-dependent inflammation and cholesterol dysregulation (2017) (73)
Podoplanin is a novel fos target gene in skin carcinogenesis. (2008) (73)
Mice lacking c-fos have normal hematopoietic stem cells but exhibit altered B-cell differentiation due to an impaired bone marrow environment (1994) (72)
Erratum: Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1 (Nature Medicine (2000) 6 (980-984)) (2000) (72)
Hepatocyte survival in acute hepatitis is due to c-Jun/AP-1-dependent expression of inducible nitric oxide synthase (2007) (72)
Oncogenes in the study of endothelial cell growth and differentiation. (1994) (70)
TNFalpha shedding and epidermal inflammation are controlled by Jun proteins. (2009) (70)
The c-Jun N-terminal kinases in cerebral microglia: immunological functions in the brain. (2002) (69)
Mitogen‐inducible gene‐6 is a negative regulator of epidermal growth factor receptor signaling in hepatocytes and human hepatocellular carcinoma (2010) (69)
Calprotectin: from biomarker to biological function (2021) (69)
Transfer of genes into embryonal carcinoma cells by retrovirus infection: efficient expression from an internal promoter. (1985) (68)
Protective Role of Raf-1 in Salmonella-Induced Macrophage Apoptosis (2001) (67)
Rhabdomyosarcoma development in mice lacking Trp53 and Fos: tumor suppression by the Fos protooncogene. (2003) (67)
Cell proliferation and cell cycle progression are not impaired in fibroblasts and ES cells lacking c-Fos. (1995) (66)
Signalling in osteoclasts and the role of Fos/AP1 proteins (2003) (66)
Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling (2009) (65)
CD44 is a determinant of inflammatory bone loss (2005) (65)
FOSL2 promotes leptin gene expression in human and mouse adipocytes. (2012) (65)
Distinct involvement of the Jun‐N‐terminal kinase and NF‐κB pathways in the repression of the human COL1A2 gene by TNF‐α (2002) (64)
Differentiation-induced skin cancer suppression by FOS, p53, and TACE/ADAM17. (2012) (64)
Introduction of a viral thymidine kinase gene and the human beta-globin gene into developmentally multipotential mouse teratocarcinoma cells. (1980) (60)
Essential role of the keratinocyte-specific endonuclease DNase1L2 in the removal of nuclear DNA from hair and nails. (2011) (60)
JunB Inhibits ER Stress and Apoptosis in Pancreatic Beta Cells (2008) (59)
Expression of foreign genes from retroviral vectors in mouse teratocarcinoma chimaeras. (1985) (57)
Osteoclast lineage commitment of bone marrow precursors through expression of membrane-bound TRANCE. (2000) (57)
Signalling in inflammatory skin disease by AP-1 (Fos/Jun). (2015) (57)
AP-1 dimers regulate transcription of the p14/p19ARF tumor suppressor gene (2005) (55)
The limited role of NH2-terminal c-Jun phosphorylation in neuronal apoptosis (2005) (54)
Fractionation of mouse bone marrow by adherence separates primitive hematopoietic stem cells from in vitro colony-forming cells and spleen colony-forming cells. (1991) (54)
Identification of the human homolog of the imprinted mouse Air non-coding RNA. (2008) (54)
Epidermal JunB represses G-CSF transcription and affects haematopoiesis and bone formation (2008) (53)
Distinct functions of junD in cardiac hypertrophy and heart failure. (2005) (52)
Inflammation-mediated skin tumorigenesis induced by epidermal c-Fos (2013) (52)
Amino-terminal phosphorylation of c-Jun regulates apoptosis in the retinal ganglion cells by optic nerve transection. (2002) (51)
EGFR controls bone development by negatively regulating mTOR-signaling during osteoblast differentiation (2018) (50)
Intramedullary and extramedullary B lymphopoiesis in osteopetrotic mice. (2000) (50)
The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment (2017) (50)
Generation of normal T and B lymphocytes by c-jun deficient embryonic stem cells. (1994) (50)
Endothelial cell transformation by polyomavirus middle T antigen in mice lacking Src-related kinases (1994) (49)
The AP-1 Transcription Factor c-Jun Prevents Stress-Imposed Maladaptive Remodeling of the Heart (2013) (48)
Wnt signaling and Loxl2 promote aggressive osteosarcoma (2020) (47)
Expression of functional human EGF receptor on murine bone marrow cells. (1988) (47)
Targeting c-Jun and JunB proteins as potential anticancer cell therapy (2008) (46)
Terminal epidermal differentiation is regulated by the interaction of Fra-2/AP-1 with Ezh2 and ERK1/2 (2015) (45)
Structure and chromosomal assignment of the mouse fra-1 gene, and its exclusion as a candidate gene for oc (osteosclerosis) (1997) (45)
A universal retroviral vector for efficient constitutive expression of exogenous genes. (1987) (45)
Fra-2-expressing macrophages promote lung fibrosis in mice. (2019) (44)
Oncogenic properties of the middle T antigens of polyomaviruses. (1994) (44)
Fra-2/AP-1 controls adipocyte differentiation and survival by regulating PPARγ and hypoxia (2014) (44)
The human alpha-1-antitrypsin gene is efficiently expressed from two tissue-specific promotors in transgenic mice. (1987) (44)
CXCL5 Facilitates Melanoma Cell-Neutrophil Interaction and Lymph Node Metastasis. (2018) (43)
The limited role of NH 2 -terminal c-Jun phosphorylation in neuronal apoptosis: Identiﬁcation of the nuclear pore complex as a potential target of the JNK pathway (2005) (43)
BCR/ABL promotes dendritic cell-mediated natural killer cell activation. (2005) (43)
Jun and JunD-dependent functions in cell proliferation and stress response (2010) (43)
Elevated Fra-1 expression causes severe lipodystrophy (2011) (43)
Acquisition of an immunosuppressive protumorigenic macrophage phenotype depending on c-Jun phosphorylation (2014) (43)
Reprogramming activity of NANOGP8, a NANOG family member widely expressed in cancer (2014) (42)
Efficient adult skeletal muscle regeneration in mice deficient in p38β, p38γ and p38δ MAP kinases (2008) (42)
The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice (2013) (41)
Control of phosphoenolpyruvate-dependent phosphotransferase-mediated sugar transport in Escherichia coli by energization of the cell membrane. (1979) (41)
AP-1 mediated retinal photoreceptor apoptosis is independent of N-terminal phosphorylation of c-Jun (2001) (40)
Osteoblast-specific expression of Fra-2/AP-1 controls adiponectin and osteocalcin expression and affects metabolism (2013) (40)
JNK1 is not essential for TNF-mediated joint disease (2004) (40)
Human foamy virus proteins accumulate in neurons and induce multinucleated giant cells in the brain of transgenic mice. (1993) (39)
FOSL1 Controls the Assembly of Endothelial Cells into Capillary Tubes by Direct Repression of αv and β3 Integrin Transcription (2013) (39)
Pancreatic β-cells activate a JunB/ATF3-dependent survival pathway during inflammation (2012) (39)
Sympathetic hyperplasia and neuroblastomas in transgenic mice expressing polyoma middle T antigen. (1990) (38)
Efficient adult skeletal muscle regeneration in mice deficient in p38beta, p38gamma and p38delta MAP kinases. (2008) (38)
Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src. (1993) (38)
The AP-1 transcription factor Fra1 inhibits follicular B cell differentiation into plasma cells (2014) (38)
Somatic Excision Demonstrates that c-Jun Induces Cellular Migration and Invasion through Induction of Stem Cell Factor (2006) (37)
Stable murine chondrogenic cell lines derived from c‐fos‐induced cartilage tumors (1993) (37)
JUNB/AP-1 controls IFN-γ during inflammatory liver disease. (2013) (37)
Distinct involvement of the Jun-N-terminal kinase and NF-kappaB pathways in the repression of the human COL1A2 gene by TNF-alpha. (2002) (37)
Impaired Wnt signaling in embryonal rhabdomyosarcoma cells from p53/c-fos double mutant mice. (2010) (37)
Expression of functional c‐kit receptors rescues the genetic defect of W mutant mast cells. (1991) (36)
Cancer metabolism: A waste of insulin interference (2015) (35)
Role of the ATFa/JNK2 complex in Jun activation (1999) (35)
The role of the transcription factor AP-1 in colitis-associated and β-catenin-dependent intestinal tumorigenesis in mice (2008) (35)
Mice with a fra-1 knock-in into the c-fos locus show impaired spatial but regular contextual learning and normal LTP. (2004) (34)
Localization of regulatory elements controlling human MYCN expression. (1991) (33)
Decreased rhodopsin regeneration in diabetic mouse eyes. (1994) (33)
Fos Proteins Suppress Dextran Sulfate Sodium-Induced Colitis through Inhibition of NF-κB (2009) (33)
Disruption of c-Jun reduces cellular migration and invasion through inhibition of c-Src and hyperactivation of ROCK II kinase. (2008) (32)
Loss of JUNB/AP-1 promotes invasive prostate cancer (2014) (32)
Expression of v-src induces aberrant development and twinning in chimaeric mice. (1991) (32)
Normal mineralization and nanostructure of sclerotic bone in mice overexpressing Fra-1. (2004) (32)
Development of Escherichia coli virus T1. The role of the proton-motive force. (1980) (31)
Cancer: Fibroblasts for all seasons (2016) (31)
Role of heterodimerization of c-Fos and Fra1 proteins in osteoclast differentiation. (2007) (31)
EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer (2012) (30)
Efficient keratinocyte differentiation strictly depends on JNK-induced soluble factors in fibroblasts. (2014) (30)
Gene transfer into murine stem cells and mice using retroviral vectors. (1985) (30)
Human Foamy Virus: An Underestimated Neuropathogen? (1991) (29)
Epidermal-specific deletion of CD44 reveals a function in keratinocytes in response to mechanical stress (2016) (29)
JunD suppresses bone formation and contributes to low bone mass induced by estrogen depletion (2008) (29)
Fra‐1 substitutes for c‐Fos in AP‐1‐mediated signal transduction in retinal apoptosis (2002) (28)
Activator protein 1 transcription factor fos‐related antigen 1 (fra‐1) is dispensable for murine liver fibrosis, but modulates xenobiotic metabolism (2014) (26)
On transferring genes into stem cells and mice. (1990) (26)
The effects of v-src expression on the differentiation of embryonal carcinoma cells. (1988) (26)
Interstitial lung disease induced by gefitinib and Toll-like receptor ligands is mediated by Fra-1 (2011) (24)
Expression of v-src arrests murine glial cell differentiation. (1989) (24)
NF1 regulates mesenchymal glioblastoma plasticity and aggressiveness through the AP-1 transcription factor FOSL1 (2019) (24)
Simultaneous generation of fra‐2 conditional and fra‐2 knock‐out mice (2007) (24)
Induction of DNA synthesis in primary mouse hepatocytes is associated with nuclear pro-transforming growth factor alpha and erbb-1 and is independent of c-jun. (2003) (24)
Formation of transformed endothelial cells in the absence of VEGFR-2/Flk-1 by Polyoma middle T oncogene (1999) (24)
Characterization of fos-induced osteogenic tumours and tumour-derived murine cell lines. (1990) (24)
Deficiency of DNA ligase activity in Fanconi's anemia (1978) (23)
Osteogenic capillaries orchestrate growth plate-independent ossification of the malleus (2015) (23)
JunB is a gatekeeper for B-lymphoid leukemia (2007) (23)
Transfer of nonselectable genes into mouse teratocarcinoma cells and transcription of the transferred human beta-globin gene (1982) (22)
Psoriatic skin inflammation is promoted by c‐Jun/AP‐1‐dependent CCL2 and IL‐23 expression in dendritic cells (2021) (22)
Expression of v-src induces a myeloproliferative disease in bone-marrow-reconstituted mice. (1989) (22)
EGFR is required for FOS‐dependent bone tumor development via RSK2/CREB signaling (2018) (22)
C-jun Inhibits Mammary Apoptosis In Vivo (2010) (22)
Chronic systemic inflammation originating from epithelial tissues (2017) (21)
Role of IL-17A signalling in psoriasis and associated bone loss. (2016) (21)
Expression of human CSF-1 receptor induces CSF-1-dependent proliferation in murine myeloid but not in T-lymphoid cells. (1991) (20)
Imprintedexpressionof the Igf 2 r genedepends onan intronicCpG island (1997) (20)
Expression of human foamy virus is differentially regulated during development in transgenic mice. (1992) (20)
Activation of HIV transcription by human foamy virus in transgenic mice. (1995) (20)
Plasminogen-dependent and -independent Proteolytic Activity of Murine Endothelioma Cells with Targeted Inactivation of Fibrinolytic Genes (1997) (19)
A putative role for c‐Fos in the pathophysiology of paget's disease (1999) (18)
p38α controls erythroblast enucleation and Rb signaling in stress erythropoiesis (2011) (18)
Pharmacologic Activation of LXR Alters the Expression Profile of Tumor-Associated Macrophages and the Abundance of Regulatory T Cells in the Tumor Microenvironment (2020) (18)
Fos-dependent induction of Chk1 protects osteoblasts from replication stress (2014) (17)
Opposing Roles of JNK and p38 in Lymphangiogenesis in Melanoma. (2016) (15)
Development of a lethal mast cell disease in mice reconstituted with bone marrow cells expressing the v-erbB oncogene. (1992) (15)
Integration and expression of genes introduced into mouse embryos (1987) (15)
An immune-sympathetic neuron communication axis guides adipose tissue browning in cancer-associated cachexia (2022) (15)
Infarct volume after transient middle cerebral artery occlusion (MCAo) can be reduced by attenuation but not by inactivation of c-Jun action (2007) (14)
Role of bulge epidermal stem cells and TSLP signaling in psoriasis (2019) (14)
Expression of c-src and c-abl in embryonal carcinoma cells and adult mouse tissues. (1988) (14)
The AP-1 transcription factor Fra1 inhibits follicular B cell differentiation into plasma cells (2014) (14)
Functions of Fos phosphorylation in bone homeostasis, cytokine response and tumourigenesis (2011) (13)
Activated Fps/Fes partially rescues the in vivo developmental potential of Flk1-deficient vascular progenitor cells. (2004) (13)
In vivo CRISPR inactivation of Fospromotes prostate cancer progression by altering the associated AP-1 subunit Jun (2021) (13)
Development of Escherichia coli virus T1: escape from host restriction (1979) (12)
Fra-2 negatively regulates postnatal alveolar septation by modulating myofibroblast function. (2017) (11)
Function of Fos proteins in bone cell differentiation. (1999) (11)
5-methylcytosine content of DNA during differentiation in mouse teratocarcinoma cells. (1979) (11)
A Role for Proto-Oncogenes in Differentiation? (1986) (11)
Development of escherichia coli virus T1. ATP-mediated discrimination of gene expression. (1980) (10)
Is the DNA of virus T7 methylated? (1979) (10)
Fra-2 Expression in Osteoblasts Regulates Systemic Inflammation and Lung Injury through Osteopontin (2018) (10)
c-Jun is essential for normal mouse development and hepatogenesis (1993) (10)
Oncogenes and Transgenic Mice (1990) (10)
Expression of collagenase-3 (MMP-13) in c-fos-induced osteosarcomas and chondrosarcomas is restricted to a subset of cells of the osteo-/chondrogenic lineage. (2001) (10)
JunB is a key regulator of multiple myeloma bone marrow angiogenesis (2021) (9)
Sequestosome 1/p62 enhances chronic skin inflammation. (2021) (9)
Cutaneous Immune Cell-Microbiota Interactions Are Controlled by Epidermal JunB/AP-1 (2019) (9)
EMBRYONIC LUNG BRANCHING MORPHOGENESIS, CELL PROLIFERATION, AND DIFFERENTIATION ARE ALTERED IN EPIDERMAL GROWTH FACTOR RECEPTOR (EGF-R) -/- TRANSGENIC 129/SV × C57BL/6 MICE. • 406 (1996) (9)
WILD TYPE p53 ACTIVITY CONTRIBUTES TO DEPENDENCE ON HEMATOPOIETIC SURVIVAL FACTORS (1994) (8)
Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration. (2018) (8)
BIOCHEMISTRY OF DEVELOPMENT OF E.COLI VIRUSES T7 AND T1 (1978) (8)
Of kit and mouse and man (1991) (8)
Embryonic overexpression of the c-Fos protooncogene. A murine stem cell chimera applicable to the study of fibrodysplasia ossificans progressiva in humans. (1998) (8)
Introduction of a selectable gene into murine T-lymphoblasts by a retroviral vector. (1986) (8)
c- fos ONCOGENE EXPRESSION IN CARTILAGE AND BONE TISSUES OF TRANSGENIC AND CHIMERIC MICE (1993) (8)
The Introduction of Genes into Mouse Embryos and Stem Cells (1992) (7)
The AP-1 transcription factors c-Jun and JunB are essential for CD8α conventional dendritic cell identity (2021) (7)
Development of Escherichia coli virus T1: repression of host gene expression. (1977) (7)
Regulate Receptor Activator of NF-B Ligand ( RANKL ) and Tumor Necrosis Factor-induced Osteoclast Precursor Differentiation by Activating c-Fos and NFATc 1 * (2007) (7)
The expression of retroviral vectors in murine stem cells and transgenic mice. (1986) (7)
Targeting AP-1 transcription factors by CRISPR in the prostate (2021) (7)
Development ofE. coli virus T1: The pattern of gene expression (1977) (6)
A novel ATP-driven glucose transport system in Escherichia coli. (1979) (6)
Topical application of an amygdalin analogue reduces inflammation and keratinocyte proliferation in a psoriasis mouse model (2021) (6)
Transgenic animals: Generation and use: edited by LM. Houdebine Harwood Academic Publishers, 1997. US$90.00/£59.00 pbk (xxii + 576 pages) ISBN 90 5702 069 6 (1997) (6)
Efficient expression of foreign genes in mice reconstituted with retrovirus-infected bone marrow cells. (1986) (6)
Factor-dependent erythroid cell lines derived from mice transplanted with hematopoietic cells expressing the v-src oncogene. (1992) (6)
Corrigendum: Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins (2006) (5)
Tumour induction in fetal brain transplants exposed to the viral oncogenes polyoma middle T and v-src. (1989) (5)
Escherichia coli virus T1: genetic controls during virus infection. (1983) (5)
Characterization of mouse model-derived osteosarcoma (OS) cells in vitro and in vivo. (2015) (5)
recessive spotting: a linked locus that interacts with W/Kit but is not allelic (1998) (5)
Early Neutrophilia Marked by Aerobic Glycolysis Sustains Host Metabolism and Delays Cancer Cachexia (2021) (5)
On the biological role of the nuclear polymerizing NAD+: protein(ADP-ribosyl) transferase (ADPRT): ADPRT from Dictyostelium discoideum and inactivation of the ADPRT gene in the mouse. (1995) (5)
The specific consequences of c-fos expression in transgenic mice. (1989) (4)
[Loss of junB expression causes a myeloproliferative syndrome resembling chronic myeloid leukemia]. (1999) (4)
Correction: Mice humanised for the EGF receptor display hypomorphic phenotypes in skin, bone and heart (2016) (4)
Radiation sensitivity of messenger RNA (1979) (4)
Mouse genetics meets molecular biology at Cold Spring Harbor. Mouse Molecular Genetics sponsored by the Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA, August 29-September 2, 1990. (1990) (4)
Exploring the Pathogenic Potential of c-fos, Polyoma Middle T and Human Foamy Virus in Transgenic Mice (1993) (4)
The AP-1 Transcription Factor JunB Promotes Multiple Myeloma (MM) Cell Proliferation, Survival and Drug Resistance in the Bone Marrow Microenvironment (2014) (4)
CD44 is a determinant of inﬂammatory bone loss (2005) (3)
Rescue of W-associated mast cell defects in W/Wv bone marrow cells by ectopic expression of normal and mutant epidermal growth factor receptors. (1993) (3)
Ordinary Voting Behavior in the Extraordinary Election of Adolf Hitler (2004) (3)
Transcriptional regulation of brain-derived neurotrophic factor mRNA levels in hippocampus by kainic acid is independent of protein synthesis and activation of calmodulin kinase IIa orc-fos (1995) (3)
Skin-derived IL-17A induces bone loss in the absence of adaptive immunity (2016) (3)
Transgenic Animals as Model Systems for Human Diseases (1995) (3)
TPL-2 Inhibits IFN-β Expression via an ERK1/2-TCF-FOS Axis in TLR4-Stimulated Macrophages (2022) (2)
C-Fos and Polyoma Middle T Oncogene Expression in Transgenic Mice and Embryonal Stem Cell Chimaeras (1989) (2)
EGFR signaling as a negative regulator of Notch1 gene expression : a differentiation/apoptosis control mechanism for proliferating keratinocytes and cancer cells (2009) (2)
NUCLEOSIDETRIPHOSPHATE MEDIATED DISCRIMINATION OF GENE EXPRESSION IN T1-INFECTED E. coli (1979) (2)
News and views on EMT Fra-1 controls EMT in mammary epithelial cells (2015) (2)
A FATal AP-1 dimer switch in hepatosteatosis (2014) (2)
Rescue of W-associated mast cell defects in W/Wv bone marrow cells by ectopic expression of normal and mutant epidermal growth factor receptors (1993) (2)
Syndecan-1 shedding by meprin β impairs keratinocyte adhesion and differentiation in hyperkeratosis. (2021) (2)
Bone cell differentiation and the role of Fos/AP-1 proteins (2003) (2)
Keratinocyte-derived S100A9 modulates neutrophil infiltration and affects psoriasis-like skin and joint disease (2022) (2)
The 3rd German-Japanese Joint Workshop. Cell Death in the CNS: Molecules and Programs (1996) (2)
Specific AP-1 (FOS/JUN) Dimers Exert Distinct Functions in Liver Cancer (2016) (1)
Late expression of c-Fos during osteoclast differentiation determines osteoclast survival and bone mass (2009) (1)
Rosacea is more than skin deep : patients have higher odds of having chronic systemic diseases in a skin severity-dependent manner (2014) (1)
Gene transfer into the germ line of mice and into embryonal carcinoma stem cells. (1984) (1)
Multiple Myeloma Pathogenesis: The Role of Junb in Bone Marrow Angiogenesis (2019) (1)
Junb Regulates Hematopoietic Stem Cell Numbers in Normal and Leukemic Mice. (2004) (1)
Editorial Overview: The ins and outs of stem cells in differentiation, inflammation & disease. (2016) (1)
Collagen VI-producing macrophages mediate lung fibrosis (2019) (1)
Gene Transfer into Mouse Stem Cells (1986) (1)
Loss of Fra-2 expression leads to osteoporosis (2003) (1)
Collagen-producing macrophages can mediate lung fibrosis throughFra-2/AP-1 expression (2018) (1)
Interleukin‐6 initiates muscle‐ and adipose tissue wasting in a novel C57BL/6 model of cancer‐associated cachexia (2022) (1)
88 THE FUNCTION OF Fos AND Fos∼Jun DIMERS IN LIVER CANCER DEVELOPMENT (2013) (1)
GENETIC DISRUPTION OF FRA-1/AP-1 TRANSCRIPTION FACTOR DECREASES SUSCEPTIBILITY TO ENDOTOXIN-INDUCED LUNG INFLAMMATION AND DEATH IN MICE (2010) (1)
Lack of vascular endothelial cell growth factor (VEGF) in murine epidermal keratinocytes results in retardation of angiogenesis-dependent processes in the skin (2001) (1)
Mo-W3:1 Adipose triglyceride lipase: Functional role in fat cell lipolysis and involvement in lipid and energy metabolism (2006) (1)
Animals and Medicines (1986) (1)
56 Analyzing Inflammation-induced Liver and Skin Cancers in AP-1(Fos/Jun)-dependent Mouse Models (2012) (0)
Directed differentiation of human embryonic stem cells and induced pluripotent stem cells to functional osteoclasts (2009) (0)
VIRUS T7: A PROBE OF CELLULAR CONTROL MECHANISMS (1979) (0)
Flow cytometry-based leukemic cell enrichment followed by mutational profiling for measurable disease detection in AML (2020) (0)
Epidermal ADAM17 provides barrier immunity and prevents myeloproliferative disease by regulating Notch-AP1 interaction (166.7) (2011) (0)
WO2-OR-5 THE ROLE OF JUNB IN FAT METABOLISM (2007) (0)
Micro- and nanostructure of mineralised tissue in mice overexpressing the transcription factor Fra-1 (2001) (0)
Nr5a2 restrains an inflammatory program in the pancreas through the regulation of AP-1 activity (2015) (0)
Transgenic mice as tools for the analysis of bone tumorigenesis and vascular diseases (1991) (0)
Role of IL-17 A signalling in psoriasis and associated bone loss Ö (2016) (0)
Notch1 and Corneal Cell Fate (2011) (0)
Abstract 2912: The AP-1 transcription factor JunB promotes multiple myeloma cell proliferation, survival and drug resistance in the bone marrow microenvironment (2016) (0)
EGFR controls bone development by negatively regulating mTOR-signaling during osteoblast differentiation (2018) (0)
c-los-induced Osteosarcoma Formation in Transgenic Mice: Cooperativity with c-jun and the Role of Endogenous c-los1 (2006) (0)
Oncogene function studied in transgenic mice and murine stem cells (1989) (0)
Summary The AP 1 transcription factor Fra 2 is required for efficient cartilage development (2004) (0)
Homologous Recombination in Embryonic Stem Cells as a Means to Generate Mice with Defined Mutations (1992) (0)
Combined targeting of distinct c-Myc and JunB transcriptional programs for multiple myeloma therapy (2019) (0)
Abstract 2336: Interplay of Fra-2/AP-1 and Ezh2/PRC2 orchestrates epidermal differentiation (2014) (0)
Embryonic overexpression of the c-Fos protooncogene: A murine stem cell chimera applicable to the study of ibrodysplasia ossificans progressiva in humans : Fibrodysplasia Ossificans Progressiva (1998) (0)
DISCUSSION OF THE PAPER (1994) (0)
When flies and mice develop cancer (2008) (0)
321 FUNCTION OF THE S100A8 AND S100A9 PROTEIN COMPLEX IN LIVER HOMEOSTASIS AND INFLAMMATION (2012) (0)
Abstract 3383: JunB/AP-1 controls MM cell proliferation, survival and drug resistance in the bone marrow microenvironment (2014) (0)
Introducing Genes into Mice and into Embryonal Carcinoma Stem Cells (1984) (0)
Genetic Disruption Of Jun/AP-1 Transcription Factor In Airways Deregulates Cigarette Smoke Induced Acute Lung Inflammation In Mice (2010) (0)
Transcriptional regulation by NR5A2 couples cell differentiation and inflammation in the pancreas (2017) (0)
How Escherichia-Coli Viruses (T1, T7) Cross the Restriction Barrier of the Host (1979) (0)
The AP-1 transcription factor Fra-1 is a negative regulator of B2B cell proliferation and of immunoglobulin class switch (111.49) (2012) (0)
Cardiac involvement in tumor-bearing mice (2022) (0)
JNK2 Regulator of Cellular Proliferation (2004) (0)
Transgenic mice for the analysis of gene function (1995) (0)
1094 URI GENERATES METABOLIC ALTERATIONS-DEPENDENT DNA DAMAGE INDUCING HETEROGENEOUS LIVER TUMOURS (2013) (0)
CANCER CELL BIOLOGY PROGRAMME (0)
A4.9 How Osteoblast Regulates Energy Metabolism and Systemic Inflammation Dependent of FRA-2 Expression (2013) (0)
DNA Repair in Human Cells: Molecular Cloning of cDNAS Coding for Enzymes Related to Repair (1988) (0)
Fra-2 transgenic mice develop a phenotype of spontaneous primary sclerosing cholangitis (2018) (0)
FRA-2 is a novel regulator of bone development affecting osteoclasts, osteoblasts and chondrocytes (2006) (0)
735 The transcription factor c-Jun/AP-1 is a central regulator of hepatocyte survival (2006) (0)
Abstract 530: The role of EGFR in c-fos-dependent osteosarcoma formation (2017) (0)
Dissecting the roles of Fra proteins in lung adenocarcinoma (2016) (0)
Bone development and the role of Fra-2 dependent cytokine signalling (2009) (0)
Molecules Receptor Expressed on Myeloid Cell 2 Involving KARAP / DAP 12-Triggering PathwayMurine Dendritic Cells : A Signaling IL-4 Confers NK Stimulatory Capacity to (2004) (0)
Abstract 202: Endogenous c-jun inhibits mammary epithelial cellular apoptosisin vivo (2011) (0)
1407 A ROLE FOR C-FOS/AP-1 IN CHOLANGIOPATHIES AND POLYCYSTIC LIVER DISEASE? (2012) (0)
Abstracts of papers presented at the 1990 Meeting on Mouse Molecular Genetics, August 29-September 2, 1990 (1990) (0)
The human alpha-1-antitrypsin gene is efficiently expressed from two tissue-specific promotors in The human alpha-l-antitrypsin gene is efriciently expressed from two tissue-specifilc promotors in transgenic mice (0)
ERK1/2 and Fra-1 mediate phosphate-dependent stimulation of matrix Gla protein expression in osteoblasts (2008) (0)
Inhibition of fra1 by the JNK-Jun pathway can protect cells against genotoxic stress (2008) (0)
Expression of AP-1- and bone/cartilage-associated genes in cell lines derived from C-FOS -induced bone and cartilage tumors (1992) (0)
Combined Targeting of Distinct c-Myc and JunB Transcriptional Programs for Multiple Myelioma Therapy (2019) (0)
Elevated FRA-1 expression causes severe lipodystrophy in the osteosclerotic FRA-1 transgenic mice (2010) (0)
Abstract 1587: Targeted deletion of Fra-1 blocks oncogenic K-ras induced lung tumor development and progression in mice (2010) (0)
Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects (2011) (0)
1st IOF-ESCEO Pre-Clinical Symposium (2011) (0)
Skin inflammation causes bone loss by IL17A-mediated inhibition of bone formation (2015) (0)
Embryonic Stem Cells as a Tool for Analyzing Mammalian Hematopoietic Development and Disease (1994) (0)
The role of oncogenes in mouse development (1986) (0)
Abstract 4632: A new mouse model for rapid identification of key factors driving prostate cancer progression and invasiveness (2019) (0)
ASBMR 25th Annual Meeting 1001–1222 (2003) (0)
Dissecting the progression of cardiac dysfunction in tumor-bearing mice (2022) (0)
and spleen colony-forming cells primitive hematopoietic stem cells from in vitro colony-forming cells Fractionation of mouse bone marrow by adherence separates (2011) (0)
Disruption Of C-Jun Transcription Factor In Alveolar Epithelium Causes Progressive Emphysema In Mice (2010) (0)
Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin (2012) (0)
Disruption Of C-Jun/AP-1 Signaling In Leucocytes Enhances Neutrophilic Inflammation In Response To LPS (2010) (0)
of Flk1-deficient vascular progenitor cells Activated Fps/Fes partially rescues the in vivo developmental potential (2013) (0)
Embryonic stem cells: a powerful tool for studying mammalian development and disease (1992) (0)
350 Role of c-Fos/AP-1 in the progression to squamous cell carcinomas (2010) (0)
Functions of FOS/AP-1 proteins in bone development and beyond (2012) (0)
Anti-tumor effector mechanisms generated by vaccination with interleukin-2 transfected murine melanoma cells (1994) (0)
FRA-1 DEFICIENCY CONFERS ENHANCED PROTECTION AGAINST OXIDANT INDUCED CELL DEATH IN VITRO (2010) (0)
Inhibits Tumor Formation Murine Epidermal Keratinocytes Delays Wound Healing and Loss of Vascular Endothelial Growth Factor A Activity in Updated (2004) (0)
The Pathophysiologic Role of JunB in Multiple Myeloma Pathogenesis: Focus on Bone Marrow Angiogenesis (2016) (0)
Effect of vascular endothelial cell growth factor (VEGF) deletion on skin biology and mammary gland development and function (2001) (0)
cachexia. Two studies in fruit flies show that inhibition of insulin signalling causes cachexia-like organ wasting. (2015) (0)
Inflammatory bowel diseases (PP-065) (2010) (0)
Interleukin-2 transfected melanoma cells for tumor vaccination. — From animal models to clinical trials — (1995) (0)
Expression of human e l-acid glycoproteln genes m cultured cells and m transgemc m ce (1988) (0)
Abstracts of papers presented at the 1988 Meeting on Mouse Molecular Genetics, August 24-August 28, 1988 (1988) (0)
Epidermal hyperplasia in mice lacking the NAD+:ADP-ribosyl-transferase (ADPRT) gene (1994) (0)
NF-of Sodium-Induced Colitis through Inhibition Fos Proteins Suppress Dextran Sulfate (2009) (0)
Apoptotic cell death in disease—Current understanding of the NCCD 2023 (2023) (0)
An immune‐neuron axis guides adipose tissue loss in cancer‐associated cachexia (2021) (0)
Corrigendum to "Syndecan-1 shedding by meprin β impairs keratinocyte adhesion and differentiation in hyperkeratosis". (2021) (0)
Publisher Correction: JunB is a key regulator of multiple myeloma bone marrow angiogenesis (2021) (0)
In vitro evaluation of a tumor vaccine based on the xenogenization of tumor cells with tetanus toxoid molecules (1999) (0)
Epidermal IL-17A leads to bone loss through inhibition of osteoblast differentiation (2012) (0)
Skin inflammation causes bone loss with reduced bone formation through systemic IL-17A release (2014) (0)

This paper list is powered by the following services:

Other Resources About Erwin Friedrich Wagner

en.wikipedia.org

What Schools Are Affiliated With Erwin Friedrich Wagner?

Erwin Friedrich Wagner is affiliated with the following schools:

Image Attributions

Image Source for Erwin Friedrich Wagner